Group 1 - Tapestry (NYSE: TPR) owns three fashion brands: Coach, Kate Spade New York, and Stuart Weitzman, primarily focusing on purses [1] - The brands under Tapestry have different product lines but share a common emphasis on handbags [1] Group 2 - The article does not provide specific financial data or performance metrics related to Tapestry or its brands [1]

Basel, June 12, 2025 – Novartis announced positive results from APPULSE-PNH, a Phase IIIB study evaluating the efficacy and safety of twice-daily oral monotherapy Fabhalta® (iptacopan) in adult patients with paroxysmal nocturnal hemoglobinuria (PNH) with Hb levels ≥10g/dL who switched from anti-C5 therapies (eculizumab or ravulizumab)1. After 24 weeks of treatment with Fabhalta, the Hb level improved on average by 2.01 g/dL (95% CI, 1.74, 2.29) with most patients achieving normal or near-normal levels 1. Da ...

LONDON, June 12, 2025 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, today announces updated long term data (up to approximately three years of follow up) from the FELIX study of obecabtagene autoleucel (obe-cel) in adult patients with relapsed/refractory (r/r) B-cell acute lymphoblastic leukemia (B-ALL), to be presented in an oral presentation at the Europe ...

The deal was inked more than a year ago. Liberty Media (NASDAQ: FWONA )(NASDAQ: FWONK ) agreed to acquire 86% of Dorna (the commercial rights holder of MotoGP) for EUR 3.0B (equity portion, to be funded mostly in cash). Initially, EU competition regulators appeared concerned. AfterStriving to compound knowledge. Long-time fan of Warren and Charlie. Always invert. "To finish first, you must first finish". Investing own and family funds for +20 years. Senior finance roles at public and private corporations fo ...

Core Viewpoint - A class action lawsuit has been filed against Rocket Pharmaceuticals, Inc. for allegedly misleading investors regarding the viability and efficacy of its gene therapy product RP-A501, particularly in relation to its Phase 2 clinical trial for Danon disease [1][2]. Group 1: Allegations and Impact - The lawsuit claims that Rocket Pharmaceuticals misrepresented the reliability of information regarding the projected timeline and safety of the RP-A501 trial, leading to a false sense of security among investors [2]. - Following the announcement of a Serious Adverse Event (SAE) involving a patient in the trial, Rocket's stock price plummeted from $6.27 per share on May 23, 2025, to $2.33 per share on May 27, 2025, reflecting a significant loss in market value [3]. Group 2: Company Background - Rocket Pharmaceuticals is described as a fully integrated, late-stage biotechnology company focused on developing gene therapies for rare and severe diseases, emphasizing its commitment to clear clinical endpoints and direct on-target mechanisms of action [1]. Group 3: Legal Proceedings - Shareholders interested in participating in the class action can contact Robbins LLP, which is leading the litigation on a contingency fee basis, meaning no fees or expenses are required from shareholders [4][5].

Lockheed Martin shares dropped as much as 7% on Wednesday after news that the Pentagon is asking for half of the F-35s it initially forecast for the Air Force. The defense contractor's shares recovered to $456 at market close, or about 4.2% lower from $476, the price at the end of Tuesday's trading day.Bloomberg reported on Wednesday that a procurement document sent to Congress indicated the Defense Department is requesting only 24 F-35 Lightning II Joint Strike Fighters for the Air Force, down from 48 tha ...

Berry Corporation (NASDAQ: BRY ) recently reported a large impairment, which caused a large decrease in the total net income. Considering that the impairment is an extraordinary event, in my view, in the coming years, we will most like to see net income growth without newBased in Europe, I am an independent investor with more than a decade of experience. I research cash flow statements and unlevered free cash flow figures. My articles may include a number of assumptions about the future free cash flow of co ...

A cryptocurrency named after GameStop Corp. GME blasted to triple-digit gains Wednesday after the video game retailer announced plans to raise over a billion dollars for investment purposes.What happened: BNB Chain BNB/USD-based GameStop Coin (GME) soared a whopping 532% in the last 24 hours, defying the broader market correction. The memecoin recorded a significant surge in trader interest, with volume jumping by 53%.GME outperformed blue-chip cryptocurrencies like Bitcoin BTC/USD and Dogecoin DOGE/USD, wh ...

In this articleNVDA"Compared to Nvidia's export-restricted chips, the performance gap between Huawei and the H20 is less than a full generation," said Dylan Patel, founder, CEO and chief analyst of SemiAnalysis. Sinology | Moment | Getty ImagesWith the U.S. restricting China from buying advanced semiconductors used in artificial intelligence development, Beijing is placing hopes on domestic alternatives such as Huawei. The task has been made more challenging by the fact that U.S. curbs not only inhibit Chin ...

I am a value investor with focus on special situations and small-cap companies. Most of the time, I write about long ideas either ones I’m already invested in or keeping an eye on until I feel confident enough to jump in. I don’t write just to have something new out there; if an idea doesn’t feel strong enough, I’m okay with walking away from it, even if I’ve already spent a lot of time digging into it.My background is in engineering, but I got into value investing after listening to the “Parsezani dar Baza ...